Aurobindo Pharma reported 21.22 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Cipla 23.56 4.18 Mar/2026
Divis Laboratories Ltd 59.75 6.76 Mar/2026
Dr.Reddys Laboratories 23.73 4.04 Mar/2026
Hindustan Unilever 50.17 5.9 Dec/2025
Sun Pharmaceuticals 39.44 5.7 Dec/2025
UPL 26.28 9.18 Mar/2026